Baricitinib
An orally available small molecule drug with potential anti-inflammatory, immunomodulating, antineoplastic and antiviral activities. Baricitinib is a globally approved treatment for rheumatoid arthritis.
Currently, there are no issues on this topic.
Find more entities like Baricitinib
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.